홈 › 난소암 › 일리노이

일리노이의 난소암 임상 시험

난소암 관련 연구 49개가 일리노이 내 여러 지역에서 참여자를 모집하고 있습니다.

일리노이의 도시

공식 연구 텍스트(영어)

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

Advocate Good Shepherd Hospital, Barrington
Illinois CancerCare-Bloomington, Bloomington
Illinois CancerCare-Canton, Canton
외 57개

피험자 모집 중2상

전 연령 · 모든 성별 · 2026. 10. 2. 업데이트됨 · NCT05564377

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

University of Chicago Hospital, Chicago

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 10. 2. 업데이트됨 · NCT06465069

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

University of Illinois Cancer Center, Chicago

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 10. 1. 업데이트됨 · NCT06172478

A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous (IV) ABBV901 Moves Through the Body Alone or in Combination With Other Anticancer Drugs in Adult Participants With Ovarian Cancer

University of Chicago Medical Center /ID# 278295, Chicago

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 9. 30. 업데이트됨 · NCT07278336

A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.

Rush Md Anderson Cancer Center /ID# 274926, Chicago
University of Chicago Medical Center /ID# 274796, Chicago
OSF St. Francis Medical Center /ID# 274752, Peoria
외 1개

피험자 모집 중2상

18세 이상 · 여성 · 2026. 9. 29. 업데이트됨 · NCT06890338

Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer

University of Chicago, Chicago

피험자 모집 중관찰 연구

18세 이상 · 여성 · 2026. 9. 29. 업데이트됨 · NCT05051722

DESTINY-PANTUMOUR04

Research Site, Decatur

피험자 모집 중관찰 연구

18세 ~ 130세 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT07124000

A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab

Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago
University of Chicago Medical Center, Chicago

피험자 모집 중1/2상

18세 이상 · 여성 · 2026. 9. 24. 업데이트됨 · NCT04590326

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

Illinois Cancer Specialists, Arlington Heights
Northwestern Memorial Hospital, Chicago
Rush University Medical Center, Chicago
외 2개

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT07213804

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

Northwestern University Feinberg School of Medicine, Chicago

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 9. 21. 업데이트됨 · NCT05983432

A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

City of Hope, Chicago, Zion

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 9. 17. 업데이트됨 · NCT07109726

A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)

Illinois Cancer Specialists (ICS) ( Site 8009), Arlington Heights

피험자 모집 중3상

18세 이상 · 여성 · 2026. 9. 17. 업데이트됨 · NCT07318558

Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression

The University of Chicago Medicine, Chicago
Carle Cancer Center, Effingham
Northshore University Health System-Evanston Hospital, Evanston
외 1개

피험자 모집 중3상

18세 이상 · 여성 · 2026. 9. 15. 업데이트됨 · NCT07214779

Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer

University of Chicago, Chicago

피험자 모집 중2상

18세 이상 · 여성 · 2026. 9. 14. 업데이트됨 · NCT06787612

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

University of Illinois Cancer Center, Chicago
University of Chicago Medicine, Chicago
City of Hope - Chicago, Zion

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 9. 10. 업데이트됨 · NCT06293898

Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer

University of Chicago, Chicago

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 9. 8. 업데이트됨 · NCT04107077

Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors

University of Chicago Medical Center, Chicago

피험자 모집 중1상

15세 이상 · 모든 성별 · 2026. 8. 25. 업데이트됨 · NCT06276491

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

Lurie Children's Hospital-Chicago, Chicago

피험자 모집 중1/2상

12 Months – 30 Years · 모든 성별 · 2026. 8. 25. 업데이트됨 · NCT04851119

Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity

Northwestern University, Chicago
University of Chicago Comprehensive Cancer Center, Chicago
Northwestern Medicine Cancer Center Old Irving Park, Chicago
외 5개

피험자 모집 중2/3상

18세 이상 · 모든 성별 · 2026. 8. 19. 업데이트됨 · NCT07001748

A Study of MUC16-Directed Antibody Drug Conjugate HWK-016 in Participants With Advanced Solid Tumors.

St. Francis Medical Center (OSF Healthcare), Peoria

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 8. 18. 업데이트됨 · NCT07470853

A Study of PHST001 in Advanced Solid Tumors

University of Chicago Medical Center, Chicago

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 8. 12. 업데이트됨 · NCT06840886

Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies

Research Site, Chicago

피험자 모집 중1/2상

18세 ~ 130세 · 모든 성별 · 2026. 8. 12. 업데이트됨 · NCT05417594

A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer

Advocate Outpatient Center - Aurora, Aurora
Advocate Good Shepherd Hospital, Barrington
Carle BroMenn Outpatient Center, Bloomington
외 35개

피험자 모집 중

35세 ~ 50세 · 여성 · 2026. 8. 7. 업데이트됨 · NCT04251052

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

OSF Saint Anthony's Health Center, Alton
Rush-Copley Medical Center, Aurora
Advocate Outpatient Center - Aurora, Aurora
외 58개

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 8. 7. 업데이트됨 · NCT06580314

Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors

St. Francis Medical Center (OSF Healthcare), Peoria

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 8. 5. 업데이트됨 · NCT07444814

A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)

Orchard Healthcare Research Inc, Skokie

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 8. 5. 업데이트됨 · NCT06330064

A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

Hope and Healing Cancer Services, Hinsdale

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 7. 30. 업데이트됨 · NCT04657068

A Trial to Evaluate Safety, Tolerability, and Preliminary Efficacy of Misetionamide (GP-2250) as Monotherapy or in Combination With Gemcitabine

Rush University Medical Center, Chicago

피험자 모집 중1상

18세 이상 · 여성 · 2026. 7. 23. 업데이트됨 · NCT03854110

Immunotherapy Platform Study in Platinum Resistant High Grade Serous Ovarian Cancer

The University of Chicago Medical Center, Chicago

피험자 모집 중2상

18세 이상 · 여성 · 2026. 7. 21. 업데이트됨 · NCT04918186

An Evaluation of Maintenance Therapy Combination Mirvetuximab Soravtansine and Olaparib

Northwestern Memorial Hospital, Chicago

피험자 모집 중2상

18세 ~ 100세 · 여성 · 2026. 7. 13. 업데이트됨 · NCT05887609

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

Ingalls Family Care Center, Calumet City
UChicago Medicine - River East, Chicago
The University Of Chicago, Chicago
외 13개

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 7. 6. 업데이트됨 · NCT04389632

Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)

Endeavor Health Evanston Kellogg Cancer Care Center, Evanston

피험자 모집 중3상

18세 이상 · 여성 · 2026. 7. 2. 업데이트됨 · NCT06819007

Integrated Cancer Repository for Cancer Research

Rush-Copley Cancer Care Center, Aurora
Rush-Copley Healthcare Center, Yorkville

피험자 모집 중관찰 연구건강한 지원자 환영

19세 ~ 110세 · 모든 성별 · 2026. 6. 29. 업데이트됨 · NCT02012699

A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors

Northwestern University, Chicago

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 6. 29. 업데이트됨 · NCT05377996

A Long-term Treatment Extension Study of Niraparib in Participants Who Completed a Prior GlaxoSmithKline/TESARO-sponsored Niraparib Study

GSK Investigational Site, Harvey

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 6. 24. 업데이트됨 · NCT04641247

A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types

Northwestern Memorial Hospital, Chicago

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 6. 4. 업데이트됨 · NCT04300556

Physical Activity Intervention Among Older Women With Gynecologic Cancers (Fit4Treatment)

Northwestern University, Chicago

피험자 모집 중

60세 이상 · 여성 · 2026. 5. 29. 업데이트됨 · NCT05743517

Study of NMS-03305293 in Adult Patients With Relapsed Ovarian Cancer

OSF Saint Francis Medical Center, Peoria

피험자 모집 중1상

18세 이상 · 여성 · 2026. 5. 28. 업데이트됨 · NCT06930755

ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors

University of Chicago Medical Center, Chicago

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 5. 13. 업데이트됨 · NCT03686124

TUBectomy With Delayed Oophorectomy in High Risk Women to Assess the Safety of Prevention

UChicago Medicine, Chicago

피험자 모집 중

25세 ~ 50세 · 여성 · 2026. 4. 6. 업데이트됨 · NCT04294927

ClinicalTrials.gov 출처, 2026. 10. 5. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.